Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04199975
Other study ID # Orthoses_Protocol_v1
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date October 4, 2019
Est. completion date September 30, 2020

Study information

Verified date December 2019
Source Chinese University of Hong Kong
Contact Chu Kay Michael Mak, FRCSEd(Orth)
Phone (852) 3505 2742
Email mmak@ort.cuhk.edu.hk
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Patients with congenital or acquired upper limb structural abnormalities and peripheral nerve or brachial plexus palsies have significant loss of function. The use of orthoses may improve function particularly in performing specific tasks for which the orthoses are designed, depending on the patients' deficiencies and needs. The performance of orthoses may be enhanced by being light-weight, motor-driven, and ergonomic.

This pilot, prospective study is designed to test the feasibility and effectiveness of the specially designed orthoses.


Recruitment information / eligibility

Status Recruiting
Enrollment 10
Est. completion date September 30, 2020
Est. primary completion date September 30, 2020
Accepts healthy volunteers No
Gender All
Age group N/A and older
Eligibility Inclusion Criteria:

- Patients with any congenital or acquired upper limb structural abnormalities

- Patients' condition is not suitable for surgical intervention or patients are not keen for surgical treatment

Exclusion Criteria:

- Patients have no available muscle signal input

- Patients fitted with a pacemaker or an implantable cardioverter defibrillator (ICD) or other implantable electrical devices

- Patients with contact dermatitis

Study Design


Related Conditions & MeSH terms

  • Upper Extremity Deformities, Congenital
  • Upper Limb Deformities, Congenital

Intervention

Device:
Orthoses
Power-Driven or Mechanical Orthoses

Locations

Country Name City State
Hong Kong Prince of Wales Hospital Shatin

Sponsors (1)

Lead Sponsor Collaborator
Chinese University of Hong Kong

Country where clinical trial is conducted

Hong Kong, 

Outcome

Type Measure Description Time frame Safety issue
Primary Visual Analogue Scale (VAS) Pain Score VAS pain score will be measured Baseline
Primary Visual Analogue Scale (VAS) Pain Score VAS pain score will be measured 1-week after
Primary Short-Form Survey (SF-36) Generic health status instrument to assess quality of life Baseline
Primary Short-Form Survey (SF-36) Generic health status instrument to assess quality of life 1-week after
Primary Active and passive range of motion (ROM) ROM will be measured to determine the joint stiffness Baseline
Primary Active and passive range of motion (ROM) ROM will be measured to determine the joint stiffness 1-week after
Primary Disability of Arm, Shoulder and Hand (DASH) questionnaire Specially designed tool to assess upper extremity disability and symptoms Baseline
Primary Disability of Arm, Shoulder and Hand (DASH) questionnaire Specially designed tool to assess upper extremity disability and symptoms 1-week after
Primary Patients' Satisfaction Score To grade the subjects' satisfaction regarding to their conditions (0=totally not satisfied; 10=fully satisfied) Baseline
Primary Patients' Satisfaction Score To grade the subjects' satisfaction regarding to their conditions (0=totally not satisfied; 10=fully satisfied) 1-week after
Primary Grip Strength Will be measured in kg Baseline
Primary Grip Strength Will be measured in kg 1-week after
See also
  Status Clinical Trial Phase
Enrolling by invitation NCT04059107 - Prosthetic Device in Children With Upper Congenital Limb Deficiency N/A